HPV immunization coverage estimates among primary target cohort (9-14) in Marshall Islands
Marshall Islands: HPV immunization coverage estimates among primary target cohort (9-14) was 70.0% in 2025. ▲ Rising
HPV immunization coverage estimates among primary target cohort (9-14) in Marshall Islands, 2010–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, hpv immunization coverage estimates among primary target cohort (9-14) in Marshall Islands stood at 70.0%.
Compared with earlier readings it is up 62.8% over ten years.
Over the whole period, hpv immunization coverage estimates among primary target cohort (9-14) in Marshall Islands peaked at 99.0% in 2016 and was at its lowest, 16.0%, in 2013.
That places Marshall Islands 60th out of 111 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 14 years of available data.
HPV immunization coverage estimates among primary target cohort (9-14) in Marshall Islands, year by year
| Year | Value | Change |
|---|---|---|
| 2010 | 37.0% | — |
| 2012 | 25.0% | -32.4% |
| 2013 | 16.0% | -36.0% |
| 2014 | 65.0% | +306.2% |
| 2015 | 43.0% | -33.8% |
| 2016 | 99.0% | +130.2% |
| 2017 | 30.0% | -69.7% |
| 2019 | 91.0% | +203.3% |
| 2020 | 84.0% | -7.7% |
| 2021 | 75.0% | -10.7% |
| 2022 | 66.0% | -12.0% |
| 2023 | 48.0% | -27.3% |
| 2024 | 70.0% | +45.8% |
| 2025 | 70.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 50.8% | 16.0% | 99.0% | 8 |
| 2020s | 68.8% | 48.0% | 84.0% | 6 |
Countries ranked near Marshall Islands
- 57 Saint Kitts and Nevis 72.0% compare
- 58 Cyprus 71.0% compare
- 58 Guyana 71.0% compare
- 60 New Zealand 70.0% compare
- 60 Seychelles 70.0% compare
- 60 Czechia 70.0% compare
- 60 United Kingdom of Great Britain and Northern Ireland 70.0% compare
More health data for Marshall Islands
- Heat deaths vs projected death rates, annual growth rate 3.09 % change on previous year (2090)
- Number of infants who die before age 1 2 deaths (2100)
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Estimated changes in temperature-related death rates compared to projected death rates 1,179 deaths per 1,000 people (2090)
- Deaths in armed conflicts by region 0 deaths (2026)
- Population, male, annual growth rate -3.51 % change on previous year (2025)
- Population, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Deaths in armed conflicts based on where they occurred 0 deaths (2026)
- Population, male, per capita 0.5116 units per person (2025)
- Age population, age 19, male, interpolated 469 (2025)
Frequently asked questions
- What is hpv immunization coverage estimates among primary target cohort (9-14) in Marshall Islands?
- Hpv immunization coverage estimates among primary target cohort (9-14) in Marshall Islands was 70.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest hpv immunization coverage estimates among primary target cohort (9-14) recorded in Marshall Islands?
- The highest recorded value was 99.0% in 2016.
- What is the lowest hpv immunization coverage estimates among primary target cohort (9-14) recorded in Marshall Islands?
- The lowest recorded value was 16.0% in 2013.
- How does Marshall Islands rank for hpv immunization coverage estimates among primary target cohort (9-14)?
- Marshall Islands ranks 60th out of 111 countries with data for 2025.
- Is hpv immunization coverage estimates among primary target cohort (9-14) rising or falling in Marshall Islands?
- Over the last ten years it is up 62.8%. The long-run trend across the full record is rising.
- Where does this Marshall Islands data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 14 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).